Search Page
Save citations to file
Email citations
            Email address has not been verified. Go to
            
              My NCBI account settings
            
            to confirm your email and then refresh this page.
          
        Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results | 
|---|---|
| 2016 | 1 | 
| 2018 | 1 | 
| 2020 | 1 | 
| 2025 | 0 | 
Search Results
3 results
Results by year
        Filters applied: . Clear all
      
    
    Page 1
  
  
  
  
    
      
  
        
          
            
            
            
              
                Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial.
              
            
            
            
              
            
            
              
            
          
        
      
      
        
  
      
    
  
    
      
        
        
      
    
    
    Leuk Lymphoma. 2018 Sep;59(9):2135-2143. doi: 10.1080/10428194.2017.1421758. Epub 2018 Jan 11.
    Leuk Lymphoma. 2018.
  
  
  PMID: 29322849
  
  
    
  
  Clinical Trial.
  
  
          
        
        
          
        
          
            
            
            
              
                Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels.
              
            
            
            
              
            
            
              
            
          
        
      
      
        
  
  
    
      
        Santini V, Almeida A, Giagounidis A, Skikne B, Beach CL, Weaver J, Tu N, Fenaux P.
        
      
    
    Santini V, et al.
    Leuk Lymphoma. 2020 Jun;61(6):1475-1483. doi: 10.1080/10428194.2020.1719088. Epub 2020 Feb 17.
    Leuk Lymphoma. 2020.
  
  
  PMID: 32064987
  Free article.
  
    
  
  
  
  
          
        
        
          
  Item in Clipboard
  
        
          
            
            
            
              
                Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents.
              
            
            
            
              
            
            
              
            
          
        
      
      
        
  
  
    
      
        Santini V, Almeida A, Giagounidis A, Gröpper S, Jonasova A, Vey N, Mufti GJ, Buckstein R, Mittelman M, Platzbecker U, Shpilberg O, Ram R, Del Cañizo C, Gattermann N, Ozawa K, Risueño A, MacBeth KJ, Zhong J, Séguy F, Hoenekopp A, Beach CL, Fenaux P.
        
      
    
    Santini V, et al.
    J Clin Oncol. 2016 Sep 1;34(25):2988-96. doi: 10.1200/JCO.2015.66.0118. Epub 2016 Jun 27.
    J Clin Oncol. 2016.
  
  
  PMID: 27354480
  
  
    
  
  Clinical Trial.
  
  
          
        
        
          
  Item in Clipboard
  
      Cite
    
    Cite
    ARTICLE TYPE
        ARTICLE LANGUAGE
        AGE
        Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.